Home Obi Profile Fees Services News Publications Contact  
You are here: Title Details
Search  
    Login
Inventions Industrial DesignTechnological Information
HUMANIZED ANTIBODIES TO LIV-1 AND USE OF SAME TO TREAT CANCER

No-Receipt date 2020-04869 - 22/12/2020
No-Filing date 20200403550 - 22/12/2020
No-Granting date 3105926 - 11/01/2021
No-EPO application date 18204152.5 - 06/12/2011
No-EPO granting date 3461847 - 23/09/2020
Gazette No-Publication date of application -
Gazette No-Publication date of granted patent 1/2021 - 15/02/2021
Expiration date 07/12/2031
Kind of title Validation of European Patent
Legal status VALID
Priorities US42029110 P06/12/2010/US
US201161446990 P25/02/2011/US
Active Substance of Supplementary Certificates -

IPC Classification
Ipc Class
A61K 39/395
A61K 47/68
A61P 35/00
C07K 16/28

Related Documents

Related Titles

Owners
CodeFirstnameSurnameAddressTownZIPCountry
1279229 SEAGEN INC. 21823 30TH DRIVE, S.E.BOTHELL, WA 98021 UNITED STATES OF AMERICA (USA)

Inventors
CodeFirstnameSurname
3171745 SMITH, MARIA LEIA
3171746 SUSSMAN, DJANGO
3171747 ARTHUR, WILLIAM
3171748 NESTEROVA, ALBINA

Representatives
CodeFirstnameSurnameAddressTownZip
745CHRISTINAKIORTSISOLONOS 136ATHINA (ATTIKIS)10677

Contact
CodeFirstnameSurnameAddressTownZipCountry
2126CHRISTINAKIORTSISOLONOS 136ATHINA (ATTIKIS)10677 GREECE

Owners History

Title Instruments

Payments history 14 renewals have been done
Print
Dues Online PaymentNational Patent RegisterOne Stop Shop (OSS)
© OBI all rights reserved designed & developed by PROFILE S.A.
Certified QMS : EN ISO 9001:2015 and ΕΝ ISO 14001:2015